drugset / Trial / NCT03316976
A Study to Evaluate the Pharmacokinetics of Dexlansoprazole 30 Milligram (mg) and 60 mg Delayed-release Capsules in Healthy Chinese Participants
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the pharmacokinetics after a single dose of dexlansoprazole 30 and 60 mg delayed-release capsules in healthy Chinese participants.
Timeline
- Start
- 2017-11-22
- Primary completion
- 2018-02-08
- Completion
- 2018-02-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexlansoprazole | Other / unclassified | 30 mg | Oral |
| Subject | Dexlansoprazole | Other / unclassified | 60 mg | Oral |
Indications
No indication recorded.